Quan Dong Nguyen, MD

ROME — In this Healio Video Perspective from the FLORetina-ICOOR meeting, Quan Dong Nguyen, MD, MSc, shares the latest achievements in two areas: intermediate age-related macular degeneration and Stargardt disease.

In this video from the virtual Euretina congress, Quan Dong Nguyen, MD, MSc, speaks about ABY-035, a novel biologic compound that has been demonstrated to be a potent interleukin-17A inhibitor with unique pharmacological properties.

At the virtual Euretina meeting, Quan Dong Nguyen, MD, discusses local therapies for noninfectious uveitis, an approach that avoids the side effects of systemic treatment.